相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Daptomycin Nonsusceptible Enterococci: An Emerging Challenge for Clinicians
Theodoros Kelesidis et al.
CLINICAL INFECTIOUS DISEASES (2011)
Management of multidrug-resistant enterococcal infections
C. A. Arias et al.
CLINICAL MICROBIOLOGY AND INFECTION (2010)
Comparison of Outcomes From Daptomycin or Linezolid Treatment for Vancomycin-Resistant Enterococcal Bloodstream Infection: A Retrospective, Multicenter, Cohort Study
Christopher W. Crank et al.
CLINICAL THERAPEUTICS (2010)
A potential role for daptomycin in enterococcal infections: what is the evidence?
Rafael Canton et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
Leonard A. Mermel et al.
CLINICAL INFECTIOUS DISEASES (2009)
Vancomycin-resistant enterococcal bacteraemia: is daptomycin as effective as linezolid?
Vidya Mave et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Daptomycin Therapy for Vancomycin-Resistant Enterococcal Bacteremia: A Retrospective Case Series of 30 Patients
Jason C. Gallagher et al.
PHARMACOTHERAPY (2009)
New antimicrobial agents for the treatment of Gram-positive bacterial infections
D. Y. Aksoy et al.
CLINICAL MICROBIOLOGY AND INFECTION (2008)
Emergence and management of drug-resistant enterococcal infections
Cesar A. Arias et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2008)
The future should not look like the past
[Anonymous]
LANCET INFECTIOUS DISEASES (2006)
Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study
H Wisplinghoff et al.
CLINICAL INFECTIOUS DISEASES (2004)
Safety, efficacy and pharmacokinetics of linezolid for treatment of resistant Gram-positive infections in cancer patients with neutropenia
PF Smith et al.
ANNALS OF ONCOLOGY (2003)
Quinupristin-dalfopristin and linezolid: Evidence and opinion
GM Eliopoulos
CLINICAL INFECTIOUS DISEASES (2003)
Nosocomial superinfections due to linezolid-resistant Enterococcus faecalis: Evidence for a gene dosage effect on linezolid MICs
KA Ruggero et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2003)
Nosocomial spread of linezolid-resistant, vancomycin-resistant enterococcus faecium
IA Herrero et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Treatment of vancomycin-resistant Enterococcus faecium infections with quinupristin/dalfopristin
PK Linden et al.
CLINICAL INFECTIOUS DISEASES (2001)
Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia - A prospective multicenter study
EN Vergis et al.
ANNALS OF INTERNAL MEDICINE (2001)
Vancomycin-resistant enterococci among chronic hemodialysis patients: A prospective study of acquisition
EMC D'Agata et al.
CLINICAL INFECTIOUS DISEASES (2001)
A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia
SM Bhavnani et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2000)
Inadequate antimicrobial treatment: An important determinant of outcome for hospitalized patients
MH Kollef
CLINICAL INFECTIOUS DISEASES (2000)
分享论文
